Ortho Clinical Diagnostics Holdings plc (OCDX)

NASDAQ: OCDX · IEX Real-Time Price · USD
18.59 -0.47 (-2.47%)
Jan 18, 2022 4:00 PM EST - Market closed
Market Cap4.41B
Revenue (ttm)1.77B
Net Income (ttm)-211.90M
Shares Out237.17M
EPS (ttm)-0.42
PE Ration/a
Forward PE22.27
Dividendn/a
Ex-Dividend Daten/a
Volume1,144,027
Open18.76
Previous Close19.06
Day's Range18.53 - 19.02
52-Week Range15.14 - 22.99
Betan/a
AnalystsBuy
Price Target24.73 (+33.0%)
Earnings DateNov 3, 2021

About OCDX

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in b...

IndustryHealth Care Equipment & Supplies
IPO DateJan 28, 2021
Employees4,700
Stock ExchangeNASDAQ
Ticker SymbolOCDX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for OCDX stock is "Buy." The 12-month stock price forecast is 24.73, which is an increase of 33.03% from the latest price.

Price Target
$24.73
(33.03% upside)
Analyst Consensus: Buy

News

Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021

Expects 4Q Reported and Constant Currency Core Revenue Growth of ~4% Fiscal Year Reported and Constant Currency Core Revenue Growth of ~16% and ~15%, respectively

1 week ago - GlobeNewsWire

ORTHO CLINICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequa...

NEW ORLEANS, Jan. 4, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

2 weeks ago - PRNewsWire

Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Conference

RARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that m...

2 weeks ago - GlobeNewsWire

OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher

Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion.

Other symbols:QDEL
3 weeks ago - InvestorPlace

Ortho Clinical (OCDX) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Ortho Clinical D...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) to Quidel Corporation is fair ...

3 weeks ago - Business Wire

JD.com Is Falling, But an M&A Bid Is Lifting This Small Nasdaq Stock Thursday

Find out why the stock market could see more gains.

Other symbols:JD
3 weeks ago - The Motley Fool

Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights

Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in the combined company,  The offer price rep...

Other symbols:QDEL
3 weeks ago - Benzinga

Quidel buying Ortho Clinical Diagnostics in $6 billion deal

Quidel Corp. QDEL, -0.42% said Thursday it agreed to acquire Ortho Clinical Diagnostics Holdings Plc OCDX, +1.54% for $24.68 per share of common stock in cash and newly issued shares in the combined com...

Other symbols:QDEL
3 weeks ago - Market Watch

Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

SAN DIEGO & RARITAN, N.J.--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into ...

Other symbols:QDEL
3 weeks ago - Business Wire

Ortho Clinical Diagnostics to Participate in the 4th Annual Evercore ISI HealthCONx Conference

RARITAN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) --  Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that members of it...

1 month ago - GlobeNewsWire

OCDX or DOCS: Which Is the Better Value Stock Right Now?

OCDX vs. DOCS: Which Stock Is the Better Value Option?

Other symbols:DOCS
2 months ago - Zacks Investment Research

Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021

RARITAN, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it will repo...

3 months ago - GlobeNewsWire

Ortho Customers Rank Company No. 1 in Service and Support for Sixth Consecutive Year

Company receives top customer rating across six categories in the 2021 IMV ServiceTrak™ Awards RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) today ...

3 months ago - PRNewsWire

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities

New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnosti...

3 months ago - PRNewsWire

Ortho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwrite...

RARITAN, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world's largest pure-play in vitro diagnostics companies, today annou...

4 months ago - GlobeNewsWire

Ortho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary Shares

RARITAN, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world's largest pure-play in vitro diagnostics companies, today annou...

4 months ago - GlobeNewsWire

Ortho Clinical Diagnostics Announces Secondary Offering of Ordinary Shares

RARITAN, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world's largest pure-play in vitro diagnostics companies, today annou...

4 months ago - GlobeNewsWire

Ortho Clinical Diagnostics to Participate in September Investor Conferences

RARITAN, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, today announced that ...

4 months ago - GlobeNewsWire

Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocaps...

-- Ortho's new VITROS® Anti-SARS-CoV-2 Total N test detects the individual's immune response to the COVID-19 virus and is intended to help clinicians understand if their patient had a recent or prior CO...

5 months ago - PRNewsWire

Ortho Clinical Diagnostics Reports Second Quarter 2021 Results

Strong Revenue Growth Drives Financial Results

5 months ago - GlobeNewsWire

ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in Canada

RARITAN, N.J., July 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTI...

5 months ago - PRNewsWire

Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021

RARITAN, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it will report results fo...

5 months ago - GlobeNewsWire

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Crit...

RARITAN, N.J., July 22, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Immunodiagnostic ...

5 months ago - PRNewsWire

Ortho Clinical Diagnostics' COVID-19 Antibody Test Gets FDA Emergency Use Approval

The FDA has granted Emergency Use Authorization (EUA) to Ortho Clinical Diagnostics' (NASDAQ: OCDX) VITROS Anti-SARS-CoV-2 IgG Quantitative Test. The company says it the first quantitative COVID-19 IgG ...

6 months ago - Benzinga

Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization

- Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians an...

6 months ago - PRNewsWire